Similar articles for PMID: 26155399

Year	Number of Results
1999	1
2000	1
2005	1
2007	4
2008	2
2009	2
2010	1
2011	2
2013	7
2014	5
2015	15
2016	12
2017	10
2018	14
2019	6
2020	1
2021	5
2022	5
2023	5
2024	0

1

Akt1 and -2 inhibition diminishes terminal differentiation and enhances central memory CD8⁺ T-cell proliferation and survival.

Abu Eid R, Friedman KM, Mkrtichyan M, Walens A, King W, Janik J, Khleif SN. Abu Eid R, et al. Oncoimmunology. 2015 Feb 3;4(5):e1005448. doi: 10.1080/2162402X.2015.1005448. eCollection 2015 May. Oncoimmunology. 2015. PMID: 26155399 Free PMC article.

2

Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-δ Inhibition.

Abu Eid R, Ahmad S, Lin Y, Webb M, Berrong Z, Shrimali R, Kumai T, Ananth S, Rodriguez PC, Celis E, Janik J, Mkrtichyan M, Khleif SN. Abu Eid R, et al. Cancer Res. 2017 Aug 1;77(15):4135-4145. doi: 10.1158/0008-5472.CAN-16-1925. Epub 2017 Jun 14. Cancer Res. 2017. PMID: 28615225

3

Comparison of naïve and central memory derived CD8⁺ effector cell engraftment fitness and function following adoptive transfer.

Wang X, Wong CW, Urak R, Taus E, Aguilar B, Chang WC, Mardiros A, Budde LE, Brown CE, Berger C, Forman SJ, Jensen MC. Wang X, et al. Oncoimmunology. 2015 Aug 20;5(1):e1072671. doi: 10.1080/2162402X.2015.1072671. eCollection 2016. Oncoimmunology. 2015. PMID: 26942092 Free PMC article.

4

Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.

Hinrichs CS, Borman ZA, Cassard L, Gattinoni L, Spolski R, Yu Z, Sanchez-Perez L, Muranski P, Kern SJ, Logun C, Palmer DC, Ji Y, Reger RN, Leonard WJ, Danner RL, Rosenberg SA, Restifo NP. Hinrichs CS, et al. Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17469-74. doi: 10.1073/pnas.0907448106. Epub 2009 Sep 24. Proc Natl Acad Sci U S A. 2009. PMID: 19805141 Free PMC article.

5

Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.

Wu F, Zhang W, Shao H, Bo H, Shen H, Li J, Liu Y, Wang T, Ma W, Huang S. Wu F, et al. Cancer Lett. 2013 Oct 10;339(2):195-207. doi: 10.1016/j.canlet.2013.06.009. Epub 2013 Jun 18. Cancer Lett. 2013. PMID: 23791878

6

WASp Deficiency Selectively Affects the TCR Diversity of Different Memory T Cell Subsets in WAS Chimeric Mice.

Li W, Jia Y, Wang Y, Zhao Q, Yang L, Zeng T, Niu L, Dai R, Li Y, Zhao X, Wu J. Li W, et al. Front Immunol. 2022 Jan 18;12:794795. doi: 10.3389/fimmu.2021.794795. eCollection 2021. Front Immunol. 2022. PMID: 35116029 Free PMC article.

7

Modulation of intracellular kinase signaling to improve TIL stemness and function for adoptive cell therapy.

Feng H, Qiu L, Shi Z, Sheng Y, Zhao P, Zhou D, Li F, Yu H, You Y, Wang H, Li M, Zhu S, Du Y, Cui J, Sun J, Liu Y, Jiang H, Wu X. Feng H, et al. Cancer Med. 2023 Feb;12(3):3313-3327. doi: 10.1002/cam4.5095. Epub 2022 Aug 26. Cancer Med. 2023. PMID: 36028997 Free PMC article.

8

Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.

Moogk D, Zhong S, Yu Z, Liadi I, Rittase W, Fang V, Dougherty J, Perez-Garcia A, Osman I, Zhu C, Varadarajan N, Restifo NP, Frey AB, Krogsgaard M. Moogk D, et al. J Immunol. 2016 Jul 15;197(2):644-54. doi: 10.4049/jimmunol.1600178. Epub 2016 Jun 6. J Immunol. 2016. PMID: 27271569 Free PMC article.

9

CD40 ligand-expressing recombinant vaccinia virus promotes the generation of CD8(+) central memory T cells.

Trella E, Raafat N, Mengus C, Traunecker E, Governa V, Heidtmann S, Heberer M, Oertli D, Spagnoli GC, Zajac P. Trella E, et al. Eur J Immunol. 2016 Feb;46(2):420-31. doi: 10.1002/eji.201545554. Epub 2015 Dec 2. Eur J Immunol. 2016. PMID: 26561341 Free article.

10

Neem leaf glycoprotein promotes dual generation of central and effector memory CD8(+) T cells against sarcoma antigen vaccine to induce protective anti-tumor immunity.

Ghosh S, Sarkar M, Ghosh T, Guha I, Bhuniya A, Saha A, Dasgupta S, Barik S, Bose A, Baral R. Ghosh S, et al. Mol Immunol. 2016 Mar;71:42-53. doi: 10.1016/j.molimm.2016.01.007. Epub 2016 Feb 3. Mol Immunol. 2016. PMID: 26851529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year